Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

4563:JP

229.0 JPY 2.0 0.87%

As of 02:00:00 ET on 05/01/2015.

Snapshot for AnGes MG Inc (4563)

Open: 230.0 Day's Range: 224.0 - 231.0 Volume: 609,500
Previous Close: 231.0 52wk Range: 224.0 - 562.1 1-Yr Rtn: -34.60%

Stock Chart for 4563

No chart data available.
  • 4563:JP 230.0
  • 1D
  • 1M
  • 1Y
231.0
Interactive 4563 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4563

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -69.9210
Est. EPS (JPY) (12/2015) -108.3000
Est. PEG Ratio -
Market Cap (M JPY) 12,547.91
Shares Outstanding (M) 54.79
30 Day Average Volume 453,643
Price/Book (mrq) 1.7961
Price/Sale (ttm) 11.9849
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4563

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4563

AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients. The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism. AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.

Ei YamadaPresident/CEO
More Company Profile & Key Executives for 4563

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil